US Stock MarketDetailed Quotes

INKT MiNK Therapeutics

Watchlist
  • 8.410
  • +0.490+6.19%
Close Mar 20 16:00 ET
  • 7.740
  • -0.670-7.97%
Post 16:49 ET
33.36MMarket Cap-2.94P/E (TTM)

MiNK Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
39.38%-9.56M
43.09%-1.73M
28.85%-2.99M
44.82%-2.29M
41.78%-2.54M
16.45%-15.76M
31.48%-3.04M
25.03%-4.21M
10.25%-4.15M
-4.05%-4.37M
Net income from continuing operations
51.98%-10.78M
54.88%-2.46M
64.69%-1.81M
56.40%-2.7M
32.94%-3.81M
19.77%-22.46M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.2M
26.89%-5.69M
Operating gains losses
-639.77%-1.97M
---1.79M
--0
----
----
90.44%-266.78K
----
----
----
----
Depreciation and amortization
5.29%215.44K
0.55%53.87K
17.18%62.64K
-13.11%45.1K
17.83%53.83K
68.06%204.62K
41.23%53.57K
88.02%53.45K
83.36%51.91K
68.73%45.69K
Other non cash items
--717.49K
--2.1M
---1.58M
--194.14K
--4.44K
----
----
----
----
----
Change In working capital
-84.13%459.73K
-101.69%-21.45K
29.91%-60K
-105.84%-79.63K
75.96%620.81K
-66.95%2.9M
-51.88%1.27M
-1.38%-85.6K
-60.50%1.36M
-87.25%352.81K
-Change in prepaid assets
-179.06%-194.17K
0.66%-11.01K
-161.19%-136.77K
-192.78%-40.05K
36.57%-6.35K
182.71%245.59K
69.00%-11.08K
241.01%223.52K
-45.56%43.16K
94.50%-10.01K
-Change in payables and accrued expense
-1,565.31%-1.58M
-146.02%-410.15K
48.23%-501.69K
-197.12%-564.37K
74.73%-99.99K
-98.23%107.57K
-63.36%891.2K
-300.26%-969.15K
-56.48%581.12K
-121.57%-395.61K
-Change in other working capital
-12.34%2.23M
3.21%399.7K
-12.36%578.46K
-28.92%524.78K
-4.12%727.14K
-14.57%2.54M
63.49%387.27K
261.04%660.03K
-63.72%738.26K
-32.05%758.42K
Cash from discontinued investing activities
Operating cash flow
39.38%-9.56M
43.09%-1.73M
28.85%-2.99M
44.82%-2.29M
41.78%-2.54M
16.45%-15.76M
31.48%-3.04M
25.03%-4.21M
10.25%-4.15M
-4.05%-4.37M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
70.58%-73.56K
0
61.46%-23.04K
40.69%-37.02K
-13.5K
Net PPE purchase and sale
--0
--0
--0
--0
--0
70.58%-73.56K
--0
61.46%-23.04K
40.69%-37.02K
---13.5K
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
70.58%-73.56K
--0
61.46%-23.04K
40.69%-37.02K
---13.5K
Financing cash flow
Cash flow from continuing financing activities
2,757.34%10.82M
-50.00%-3
130.52%6.81K
7,770.33%5.81M
1,597.17%5.01M
-161.68%-407.17K
-101.80%-2
497.57%2.95K
51.75%-75.7K
-48,637.74%-334.43K
Net issuance payments of debt
--5M
--0
--0
--0
--5M
--0
--0
--0
--0
--0
Net common stock issuance
1,314.31%5.8M
--0
--0
6,035.45%5.8M
--0
-203.85%-477.64K
---2
--2
37.84%-97.72K
---379.92K
Proceeds from stock option exercised by employees
-71.64%19.99K
---3
130.68%6.81K
-71.44%6.29K
-84.84%6.9K
4,317.93%70.47K
--0
497.17%2.95K
7,215.61%22.02K
6,503.19%45.5K
Cash from discontinued financing activities
Financing cash flow
2,757.34%10.82M
-50.00%-3
130.52%6.81K
7,770.33%5.81M
1,597.17%5.01M
-161.68%-407.17K
-101.80%-2
497.57%2.95K
51.75%-75.7K
-48,637.74%-334.43K
Net cash flow
Beginning cash position
-82.85%3.37M
-1.10%6.33M
-12.32%9.31M
-60.94%5.82M
-82.85%3.37M
-49.51%19.64M
-73.51%6.4M
-64.41%10.62M
-57.07%14.89M
-49.51%19.64M
Current changes in cash
107.78%1.26M
43.09%-1.73M
29.35%-2.99M
182.45%3.52M
152.28%2.46M
15.72%-16.24M
33.40%-3.04M
25.46%-4.23M
11.99%-4.26M
-12.36%-4.71M
Effect of exchange rate changes
-116.63%-54.7K
-646.04%-23.53K
-54.48%2.69K
-210.58%-19.02K
49.43%-14.84K
-230.26%-25.25K
-87.82%4.31K
141.32%5.91K
-313.01%-6.12K
-539.77%-29.34K
End cash Position
35.93%4.58M
35.93%4.58M
-1.10%6.33M
-12.32%9.31M
-60.94%5.82M
-82.85%3.37M
-82.85%3.37M
-73.51%6.4M
-64.41%10.62M
-57.07%14.89M
Free cash flow
39.66%-9.56M
43.09%-1.73M
29.23%-2.99M
45.30%-2.29M
41.96%-2.54M
17.16%-15.84M
33.40%-3.04M
25.42%-4.23M
10.66%-4.19M
-4.37%-4.38M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 39.38%-9.56M43.09%-1.73M28.85%-2.99M44.82%-2.29M41.78%-2.54M16.45%-15.76M31.48%-3.04M25.03%-4.21M10.25%-4.15M-4.05%-4.37M
Net income from continuing operations 51.98%-10.78M54.88%-2.46M64.69%-1.81M56.40%-2.7M32.94%-3.81M19.77%-22.46M29.75%-5.46M19.20%-5.12M-1.38%-6.2M26.89%-5.69M
Operating gains losses -639.77%-1.97M---1.79M--0--------90.44%-266.78K----------------
Depreciation and amortization 5.29%215.44K0.55%53.87K17.18%62.64K-13.11%45.1K17.83%53.83K68.06%204.62K41.23%53.57K88.02%53.45K83.36%51.91K68.73%45.69K
Other non cash items --717.49K--2.1M---1.58M--194.14K--4.44K--------------------
Change In working capital -84.13%459.73K-101.69%-21.45K29.91%-60K-105.84%-79.63K75.96%620.81K-66.95%2.9M-51.88%1.27M-1.38%-85.6K-60.50%1.36M-87.25%352.81K
-Change in prepaid assets -179.06%-194.17K0.66%-11.01K-161.19%-136.77K-192.78%-40.05K36.57%-6.35K182.71%245.59K69.00%-11.08K241.01%223.52K-45.56%43.16K94.50%-10.01K
-Change in payables and accrued expense -1,565.31%-1.58M-146.02%-410.15K48.23%-501.69K-197.12%-564.37K74.73%-99.99K-98.23%107.57K-63.36%891.2K-300.26%-969.15K-56.48%581.12K-121.57%-395.61K
-Change in other working capital -12.34%2.23M3.21%399.7K-12.36%578.46K-28.92%524.78K-4.12%727.14K-14.57%2.54M63.49%387.27K261.04%660.03K-63.72%738.26K-32.05%758.42K
Cash from discontinued investing activities
Operating cash flow 39.38%-9.56M43.09%-1.73M28.85%-2.99M44.82%-2.29M41.78%-2.54M16.45%-15.76M31.48%-3.04M25.03%-4.21M10.25%-4.15M-4.05%-4.37M
Investing cash flow
Cash flow from continuing investing activities 0000070.58%-73.56K061.46%-23.04K40.69%-37.02K-13.5K
Net PPE purchase and sale --0--0--0--0--070.58%-73.56K--061.46%-23.04K40.69%-37.02K---13.5K
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--070.58%-73.56K--061.46%-23.04K40.69%-37.02K---13.5K
Financing cash flow
Cash flow from continuing financing activities 2,757.34%10.82M-50.00%-3130.52%6.81K7,770.33%5.81M1,597.17%5.01M-161.68%-407.17K-101.80%-2497.57%2.95K51.75%-75.7K-48,637.74%-334.43K
Net issuance payments of debt --5M--0--0--0--5M--0--0--0--0--0
Net common stock issuance 1,314.31%5.8M--0--06,035.45%5.8M--0-203.85%-477.64K---2--237.84%-97.72K---379.92K
Proceeds from stock option exercised by employees -71.64%19.99K---3130.68%6.81K-71.44%6.29K-84.84%6.9K4,317.93%70.47K--0497.17%2.95K7,215.61%22.02K6,503.19%45.5K
Cash from discontinued financing activities
Financing cash flow 2,757.34%10.82M-50.00%-3130.52%6.81K7,770.33%5.81M1,597.17%5.01M-161.68%-407.17K-101.80%-2497.57%2.95K51.75%-75.7K-48,637.74%-334.43K
Net cash flow
Beginning cash position -82.85%3.37M-1.10%6.33M-12.32%9.31M-60.94%5.82M-82.85%3.37M-49.51%19.64M-73.51%6.4M-64.41%10.62M-57.07%14.89M-49.51%19.64M
Current changes in cash 107.78%1.26M43.09%-1.73M29.35%-2.99M182.45%3.52M152.28%2.46M15.72%-16.24M33.40%-3.04M25.46%-4.23M11.99%-4.26M-12.36%-4.71M
Effect of exchange rate changes -116.63%-54.7K-646.04%-23.53K-54.48%2.69K-210.58%-19.02K49.43%-14.84K-230.26%-25.25K-87.82%4.31K141.32%5.91K-313.01%-6.12K-539.77%-29.34K
End cash Position 35.93%4.58M35.93%4.58M-1.10%6.33M-12.32%9.31M-60.94%5.82M-82.85%3.37M-82.85%3.37M-73.51%6.4M-64.41%10.62M-57.07%14.89M
Free cash flow 39.66%-9.56M43.09%-1.73M29.23%-2.99M45.30%-2.29M41.96%-2.54M17.16%-15.84M33.40%-3.04M25.42%-4.23M10.66%-4.19M-4.37%-4.38M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.